Post-Market Surveillance PMS

Medical Device Post-Market Surveillance (PMS) & PSUR Regulatory Requirements

Updated: Jun 2025QTC Global Compliance TeamRegulatory reference content

Detailing PMS systems under EU MDR and FDA rules, PMCF program setups, and Periodic Safety Update Reports (PSUR) submission requirements.

Key answer

Post-Market Surveillance (PMS) has shifted from basic complaint logs to a proactive, systematic loop feeding clinical usage data back into risk management. Based on risk, manufacturers of Class IIa, IIb, and III devices must periodically submit a Periodic Safety Update Report (PSUR); Class I devices require a Post-Market Surveillance Report (PMSR).

Standard Design for Proactive PMCF

PMCF proactively collects clinical data for CE-marked devices to identify late-onset side effects or clinical use deviations not seen in initial tests.

  • User surveys: collecting user experience and device limitations from physicians
  • Post-market clinical studies: conducting registry or clinical tracking for high-risk implants
  • Literature monitoring: tracking published articles on same/similar device risks

FAQ

How often must the PSUR be updated?+

For Class III and IIb devices, the PSUR must be updated annually. For Class IIa devices, the PSUR must be updated at least every two years. PSURs are submitted to the Notified Body.

Next steps

If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.